COVID-19 Related Acro-Ischemic Neuropathic-like Painful Lesions in Pediatric Patients: A Case Seriese
Authors:
- Alfonso PapaAPAlfonso Papa
- Anna Maria SalzanoASAnna Maria Salzano
- Maria Teresa Di DatoMDMaria Teresa Di Dato
- Giuliano Lo BiancoGBGiuliano Lo Bianco
- Mariangela TedescoMTMariangela Tedesco
- Antonio SalzanoASAntonio Salzano
- Dariusz MyrcikDMDariusz Myrcik
- Farnad ImaniFIFarnad Imani
- Giustino VarrassiGiustino Varrassi
- Ghodrat Akhavan AkbariGAGhodrat Akhavan Akbari
- Antonella PaladiniAPAntonella Paladini
Open Access
- 17 April 2021
- journal article
- research article
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. In Press (In Press) , e113760
Abstract
Background: A variety of skin manifestations have been associated with COVID-19 infection. Acral lesions on hands and feet, closely resembling chilblains, have been reported in association with COVID-19, which are nonspecific. These acro-ischemic painful lesions have been described mainly in asymptomatic and mildly symptomatic pediatric COVID-19 positive patients, without a precise pathogenetic mechanism.COVID-19-induced chilblains may portend an indolent course and a good outcome. In young patients, the IFN-1 response induces microangiopathic changes and produces a chilblain lupus erythematosus-like eruption with vasculitic neuropathic pain features. Objectives: This paper presented a case series of pediatric patients with COVID-19-related skin lesions and neuropathic-like pain. Methods: Clinical outcomes were collected from 11 patients diagnosed with painful erythematous skin lesions with neuropathic-like pain and positive IgG for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Results: It is a mildly symptomatic condition not related to severe pain rates, and it is treated with paracetamol due to the transitory nature of the problem, which provides good results. Conclusions: A particular point of interest is skin lesion manifestation as a further indirect sign of SARS-CoV-2 infection. Due to the initial manifestation of chilblains in pauci-symptomatic pediatric patients, they need to be immediately tested and isolated. Chilblains can be considered a clinical clue to suspect SARS-CoV-2 infection and help in early diagnosis, patient triage, and infection control.Keywords
This publication has 32 references indexed in Scilit:
- Pain Processing in the Human Nervous SystemPrimary Care: Clinics in Office Practice, 2012
- The multiple pathways for itch and their interactions with painTrends in Neurosciences, 2010
- Chilblains and antiphospholipid antibodies: report of four cases and review of the literatureBritish Journal of Dermatology, 2010
- Constitutional and Behavioral Risk Factors for Chilblains: A Case-Control Study From PakistanWilderness & Environmental Medicine, 2010
- Idiopathic ChilblainsThe American Journal of Medicine, 2009
- Neuropathic painNeurology, 2008
- Mechanisms of Disease: neuropathic pain—a clinical perspectiveNature Clinical Practice Neurology, 2006
- Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)Pain, 2005
- Quantitative sensory testingPhysical Medicine and Rehabilitation Clinics of North America, 2003
- Perniosis in Association With Anorexia NervosaPediatric Dermatology, 1994